Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Rockman

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Vaccines|June 27, 2024
Analysing the Potency of a Seasonal Influenza Vaccine Using Reference Antisera from Heterologous StrainsChristine Wadey, Steven Rockman
Vaccines|September 27, 2025
Understanding the Implications of Delaying Seasonal Influenza Vaccine Recommendations: An Industry PerspectiveSteven Rockman, Karen Laurie
Human Vaccines|October 12, 2010
Pre-pandemic and pandemic influenza vaccinesSteven Rockman, Lorena Brown
Vaccines|May 13, 2020
Pandemic Influenza Vaccines: What did We Learn from the 2009 Pandemic and are We Better Prepared Now?Steven Rockman, Karen Laurie, Ian Barr
Critical Care Medicine|October 18, 2011
The use of hyperimmune serum for severe influenza infections*Steven Rockman, Darryl Maher, Deborah Middleton
Toxins|April 3, 2021
Potency Testing of Venoms and Antivenoms in Embryonated Eggs: An Ethical Alternative to Animal TestingErin E Verity, Kathy Stewart, Kirsten Vandenberg, et al.
Frontiers in Immunology|December 3, 2025
Utilisation of monoclonal antibodies in the single radial immunodiffusion assay to determine potency and stability for seasonal and pandemic influenza vaccinesJesse Bodle, David Burge, Gopal Gounder, et al.
Immunology and Cell Biology|February 24, 2010
A lipopeptide based on the M2 and HA proteins of influenza A viruses induces protective antibodyDavid Pejoski, Weiguang Zeng, Steven Rockman, et al.
Microorganisms|November 11, 2020
New Technologies for Influenza VaccinesSteven Rockman, Karen L Laurie, Simone Parkes, et al.
Scientific Reports|May 21, 2026
Using an RNA binding protein to detect mRNA on lipid nanoparticlesMeagan McMahon, Hareth Al-Wassiti, Kirsten Vandenberg, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Vaccines|June 27, 2024
Analysing the Potency of a Seasonal Influenza Vaccine Using Reference Antisera from Heterologous StrainsChristine Wadey, Steven Rockman
Vaccines|September 27, 2025
Understanding the Implications of Delaying Seasonal Influenza Vaccine Recommendations: An Industry PerspectiveSteven Rockman, Karen Laurie
Human Vaccines|October 12, 2010
Pre-pandemic and pandemic influenza vaccinesSteven Rockman, Lorena Brown
Vaccines|May 13, 2020
Pandemic Influenza Vaccines: What did We Learn from the 2009 Pandemic and are We Better Prepared Now?Steven Rockman, Karen Laurie, Ian Barr
Critical Care Medicine|October 18, 2011
The use of hyperimmune serum for severe influenza infections*Steven Rockman, Darryl Maher, Deborah Middleton
Toxins|April 3, 2021
Potency Testing of Venoms and Antivenoms in Embryonated Eggs: An Ethical Alternative to Animal TestingErin E Verity, Kathy Stewart, Kirsten Vandenberg, et al.
Frontiers in Immunology|December 3, 2025
Utilisation of monoclonal antibodies in the single radial immunodiffusion assay to determine potency and stability for seasonal and pandemic influenza vaccinesJesse Bodle, David Burge, Gopal Gounder, et al.
Immunology and Cell Biology|February 24, 2010
A lipopeptide based on the M2 and HA proteins of influenza A viruses induces protective antibodyDavid Pejoski, Weiguang Zeng, Steven Rockman, et al.
Microorganisms|November 11, 2020
New Technologies for Influenza VaccinesSteven Rockman, Karen L Laurie, Simone Parkes, et al.
Scientific Reports|May 21, 2026
Using an RNA binding protein to detect mRNA on lipid nanoparticlesMeagan McMahon, Hareth Al-Wassiti, Kirsten Vandenberg, et al.
Pageof 5